Boyne Capital (“Boyne”) a Miami, FL based private equity firm focused on lower middle market companies, announces the sale of its portfolio company, Infusion Associates (“IA” or the “Company”) to Vivo Infusion (“Vivo”). Boyne acquired IA in November of 2018. Infusion Associates, headquartered in Grand Rapids, Michigan, is a leading provider of ambulatory infusion services across the Midwest U.S. The Company specializes in long-term treatment of chronic health conditions across a range of therapeutic areas including neurology, gastroenterology, rheumatology, and immunology.
Read the full article: Boyne Capital Announces the Sale of Infusion Associates to Vivo Infusion //
Source: https://www.prnewswire.com/news-releases/boyne-capital-announces-the-sale-of-infusion-associates-to-vivo-infusion-302191538.html